Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1995;26:735-742

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meyer, J. S.
Right arrow Articles by Shirai, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meyer, J. S.
Right arrow Articles by Shirai, T.

(Stroke. 1995;26:735-742.)
© 1995 American Heart Association, Inc.


Articles

Prospective CT Confirms Differences Between Vascular and Alzheimer's Dementia

John Stirling Meyer, MD; Kazuhiro Muramatsu, MD; Karl F. Mortel, PhD; Katsuyuki Obara, MD Toshitaka Shirai, MD

From the Cerebrovascular Research Laboratories, Department of Veterans Affairs Medical Center, and the Department of Neurology, Baylor College of Medicine (J.S.M.), Houston, Tex.

Background and Purpose Cognitive test performances were correlated prospectively with changes in cerebral CT measurements of atrophy, infarct volume, ventricular enlargement, local tissue density, and local perfusion to contrast annual rates of changes among patients with ischemic vascular dementia (IVD) or dementia of the Alzheimer type (DAT).

Methods The cerebral atrophic index (ATI; ratio of cerebrospinal fluid or infarcted brain to intracranial volume), infarct volume ratio, ventricular volume ratio (VVR; ventricular volume/intracranial volume), cortical and subcortical gray and white matter local perfusion (local cerebral blood flow [LCBF]), and local Hounsfield unit (HU) density were measured concurrently and compared longitudinally with Cognitive Capacity Screening Examinations (CCSE) scores among 24 treated IVD (age, 68.2±9.7 years; follow-up, 42±27 months) and 24 DAT patients (age, 74.2±6.2 years; follow-up, 30±19 months).

Results IVD annual changes were as follows: CCSE, +1.2±5.9; ATI, +2.1%/y; VVR, +3.2%/y; and LCBF in the subcortical basal ganglia, -0.74 mL · 100 g-1 · min-1 · y-1 (-1.8%/y). DAT annual changes were as follows: CCSE, -1.8 /y; ATI, +8.1%/y; VVR, +9.6%/y; cortical LCBF, -2.0 mL · 100 g-1 · min-1 · y-1 (-5.2%/y); LCBF in the basal ganglia, -3.0 mL · 100 g-1 · min-1 · y-1 (-6.7%/y); white matter LCBF, -0.75 mL · 100 g-1 · min-1 · y-1 (-4.1%/y); and all cortical tissue densities, -0.83 HU/y (-2.1%/y). In IVD, multiple regression analyses correlated cognitive changes directly with (1) recurrent silent infarctions and (2) bidirectional changes of perfusions within frontal white matter, thalamus, and internal capsules. In DAT, cognitive declines correlated with cerebral atrophy and cortical hypoperfusion related to frontotemporal and parietal cortical polioaraiosis (decreased gray matter tissue densities).

Conclusions In IVD, recurrent strokes were not observed clinically during risk factor control, and antiplatelet therapy and cognitive impairments improved or stabilized. In DAT, cognitive performance relentlessly declined. Ischemic pathogenesis for vascular dementia is supported by the following: (1) cognitive declines correlate directly with recurrent "silent" strokes, and (2) bidirectional cognitive changes correlate directly with frontal white matter, thalamic, and internal capsular perfusional changes.


Key Words: Alzheimer's disease • cerebral blood flow • dementia • tomography




This article has been cited by other articles:


Home page
StrokeHome page
D. W. Desmond, J. T. Moroney, M. Sano, Y. Stern, and J. G. Merino
Incidence of Dementia After Ischemic Stroke: Results of a Longitudinal Study * Editorial Comment
Stroke, September 1, 2002; 33(9): 2254 - 2262.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. L. Nyenhuis, P. B. Gorelick, S. Freels, and D. C. Garron
Cognitive and functional decline in African Americans with VaD, AD, and stroke without dementia
Neurology, January 8, 2002; 58(1): 56 - 61.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
K. H. Taber, J. G. Zimmerman, H. Yonas, W. Hart, and R. A. Hurley
Applications of Xenon CT in Clinical Practice: Detection of Hidden Lesions
J Neuropsychiatry Clin Neurosci, November 1, 1999; 11(4): 423 - 425.
[Full Text] [PDF]


Home page
Arch NeurolHome page
K. Rockwood, E. Ebly, V. Hachinski, and D. Hogan
Presence and Treatment of Vascular Risk Factors in Patients With Vascular Cognitive Impairment
Arch Neurol, January 1, 1997; 54(1): 33 - 39.
[Abstract] [PDF]


Home page
Arch NeurolHome page
M. van Zagten, J. Boiten, F. Kessels, and J. Lodder
Significant Progression of White Matter Lesions and Small Deep (Lacunar) Infarcts in Patients With Stroke
Arch Neurol, July 1, 1996; 53(7): 650 - 655.
[Abstract] [PDF]